Through scientifically rigorous basic, clinical, translational, and behavioral research, the Emory CFAR will develop and disseminate effective preventions and therapeutic interventions for the global AIDS epidemic. The Emory CFAR supports and promotes the National CFAR mission by providing institutional infrastructure and leadership; conducting and implementing strategic and operational planning for HIV research; funding CFAR science cores that support interdisciplinary research; supporting the recruitment and development of faculty in HIV research; maintaining effective communications and sharing of scientific findings; and promoting interactions of the Emory CFAR with outside institutions and the community. Since the inception of the Emory CFAR in 1997, HIV research at the University has expanded dramatically. The CFAR has fostered recruitment of over thirty additional faculty and attracted substantially increased institutional support to further facilitate the growth of HIV/AIDS research. Under CFAR leadership, extramural HIV research funding at Emory has grown from $23 million ($7.7 million NIH) in 1996 to over $58 million ($29.9 million NIH) in 2005. The Emory CFAR will be led by an Executive Committee (composed of the CFAR directors, Drs. James Curran, Carlos del Rio, and Eric Hunter; the CFAR Associate directors and Associate director) and be advised by the Core directors, several key HIV/AIDS scientists at Emory, and an external and community advisory board. The Emory CFAR serves over 100 funded HIV/AIDS Investigators. Seven core facilities have been established to meet the CFAR objectives including Administrative, Developmental, and 5 science cores (Social and Behavioral Science, Clinical Research, Biostatistics, Immunology, and Virology/Drug Discovery). Services provided by these cores are critical in facilitating growth in all aspects of Emory University's five principal HIV/AIDS research domains: Vaccine Development and Testing, HIV Pathogenesis & Drug Discovery, Prevention Science, Clinical & Translational Science, and International Research. The CFAR will foster development of the next generation of HIV/AIDS researchers through training and mentorship of domestic and international investigators. ? ? ? CORE A: Administrative (Curran, James W.) ? ? CORE A DESCRIPTION (provided by applicant): Under the direction of the three Emory CFAR co-directors, Drs. James Curran, Carlos del Rio and .Erie Hunter, the Administrative Core is responsible for overall management of the Emory CFAR. The Administrative Core has the following objectives: ? ? 1. Provide institutional leadership and planning for HIV research at Emory ? ? 2. Support interdisciplinary HIV research by implementing the strategic plan; prioritizing, funding and evaluating cores; and recruiting and supporting the development of faculty. ? ? 3. Provide responsible, accountable and flexible oversight of the CFAR resources ? ? 4. Foster and maintain effective scientific communications within Emory, as well as promote interactions with colleagues in other institutions, international collaborators and the community. ? ? These objectives will be met through a variety of mechanisms involving CFAR administrators, investigators, outside advisors, and collaborators who will provide fiscal, administrative, scientific, and management oversight of Core facilities, services, communication, outreach, and education activities. ? ? The mission of the Administrative Core is to lead, enable, and enhance HIV research by supporting a multi-disciplinary environment that promotes basic, clinical, behavioral, and translational research in the prevention, detection, and treatment of HIV infection and AIDS. The principal activities of the Administrative Core are the selection, funding, and evaluation of basic, clinical, and developmental Cores; leadership of an annual strategic planning process that includes a retreat of the CFAR Advisory Board and Internal Scientific Review Committee, CFAR investigator surveys, and a review by the CFAR External Scientific Review Committee; a focus on recruitment and development of new and minority investigators, the establishment of international and inter-Institutional HIV research collaborations; and the hosting of a variety of community educational, and skills building opportunities for CFAR scientists and the community. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050409-10
Application #
7477730
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Program Officer
Namkung, Ann S
Project Start
2002-09-30
Project End
2012-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
10
Fiscal Year
2008
Total Cost
$1,665,424
Indirect Cost
Name
Emory University
Department
Type
Schools of Public Health
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Dillard, Rebecca S; Hampton, Cheri M; Strauss, Joshua D et al. (2018) Biological Applications at the Cutting Edge of Cryo-Electron Microscopy. Microsc Microanal 24:406-419
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Ke, Zunlong; Dillard, Rebecca S; Chirkova, Tatiana et al. (2018) The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses 10:
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Adimora, Adaora A; Ramirez, Catalina; Benning, Lorie et al. (2018) Cohort Profile: The Women's Interagency HIV Study (WIHS). Int J Epidemiol 47:393-394i
Auld, Sara C; Shah, N Sarita; Mathema, Barun et al. (2018) Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities. Eur Respir J 52:
Nelson, Kristin N; Shah, N Sarita; Mathema, Barun et al. (2018) Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa. J Infect Dis 218:1964-1973
Serota, David P; Rosenberg, Eli S; Lockard, Annie M et al. (2018) Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia. Clin Infect Dis 67:965-970
Hightow-Weidman, Lisa B; Muessig, Kathryn; Rosenberg, Eli et al. (2018) University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development. JMIR Res Protoc 7:e10365
Reyes-Robles, Tamara; Dillard, Rebecca S; Cairns, Lynne S et al. (2018) Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J Bacteriol :

Showing the most recent 10 out of 1005 publications